AMG logo

AMG

Affiliated Managers Group Inc.

$309.46
+$7.50(+2.48%)
66
Overall
80
Value
60
Tech
60
Quality
How is this score calculated?
Market Cap
$7.29B
Volume
122.81K
52W Range
$172.54 - $334.78
Target Price
$379.86

Company Overview

Mkt Cap$7.29BPrice$309.46
Volume122.81KChange+2.48%
P/E Ratio10.2Open$304.08
Revenue$2.1BPrev Close$301.96
Net Income$716.6M52W Range$172.54 - $334.78
Div Yield0.04%Target$379.86
Overall66Value80
Quality60Technical60

No chart data available

About Affiliated Managers Group Inc.

Affiliated Managers Group, Inc., through its affiliates, operates as an investment management company providing investment management services to mutual funds, institutional clients,retails and high net worth individuals in the United States. It provides advisory or sub-advisory services to mutual funds. These funds are distributed to retail, high net worth and institutional clients directly and through intermediaries, including independent investment advisors, retirement plan sponsors, broker-dealers, major fund marketplaces, and bank trust departments. The company also offers investment products in various investment styles in the institutional distribution channel, including small, small/mid, mid, and large capitalization value and growth equity, and emerging markets. In addition, it offers quantitative, alternative, and fixed income products, and manages assets for foundations and endowments, defined benefit, and defined contribution plans for corporations and municipalities. Affiliated Managers Group provides investment management or customized investment counseling and fiduciary services. Affiliated Managers Group, Inc. was formed in 1993 and is based in West Palm Beach, Florida with additional offices in Prides Crossing, Massachusetts; Stamford, Connecticut; London, United Kingdom; Dubai, United Arab Emirates; Sydney, Australia; Hong Kong; Tokyo, Japan, Zurich, Switzerland and Delaware.

Sector: Financial Services
Industry: Asset Management

Latest News

Amgen Expands Lung Cancer Pipeline With New Tarlatamab Combo Study

Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. has launched a phase 1b study in small cell lung cancer that test...

TipRanks Clinical-Trials-Auto-Generated Newsdesk4 days ago

Amgen Shareholders Reaffirm Board, Pay and Auditors

TipRanks Auto-Generated Newsdesk6 days ago

Amgen Advances Xaluritamig Trial in Hard-to-Treat Prostate Cancer

TipRanks Clinical-Trials-Auto-Generated Newsdesk6 days ago

Amgen Earnings Call Highlights Growth Amid Headwinds

TipRanks Auto-Generated Newsdesk7 days ago

Amgen Announces CFO Transition and Leadership Succession Plan

TipRanks Auto-Generated Newsdesk7 days ago
ABCD
1SymbolPriceChangeVol
2AMG$309.46+2.5%122.81K
3
4
5
6

Get Affiliated Managers Group Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.